BMET-26 PHASE 2 STUDY OF VB-111, AN ANTI-CANCER GENE THERAPY, AS MONOTHERAPY FOLLOWED BY COMBINATION OF VB-111 WITH BEVACIZUMAB, IN PATIENTS WITH RECURRENT GLIOBLASTOMA

Những quyển sách tương tự

• NT-07 PHASE 1-2 DOSE-ESCALATION STUDY OF VB-111, AN ANTI-ANGIOGENIC GENE THERAPY, AS MONOTHERAPY AND IN COMBINATION WITH BEVACIZUMAB, IN PATIENTS WITH RECURRENT GLIOBLASTOMA
  Bằng: Brenner, Andrew, et al.
  Được phát hành: (2014)
• NIMG-47. VOLUMETRIC ANALYSIS OF PHASE 2 AND 3 TRIALS IN RECURRENT GLIOBLASTOMA TREATED WITH VB-111 WITH OR WITHOUT BEVACIZUMAB OR BEVACIZUMAB MONOTHERAPY
  Bằng: Ellingson, Benjamin, et al.
  Được phát hành: (2019)
• ATIM-03. BIOMARKER ANALYSIS SUPPORTS THE VB-111 DUAL MECHANISM OF ACTION
  Bằng: Gruslova, Aleksandra, et al.
  Được phát hành: (2017)
• VB-111: A novel anti-vascular therapeutic for glioblastoma multiforme
  Bằng: Gruslova, Aleksandra, et al.
  Được phát hành: (2015)
• Safety and efficacy of VB-111, an anticancer gene therapy, in patients with recurrent glioblastoma: results of a phase I/II study
  Bằng: Brenner, Andrew J, et al.
  Được phát hành: (2020)